We looked at about 30 enzymes and identified three that are highly indicative of mastitis," Bossmann said. "These three enzymes and this nanoplatform make it possible to detect preclinical mastitis cases that have high enzymatic activity but a low somatic cell count. These cases have previously been undiscoverable, so there is not a test on the market for this combination."